StreetInsider.com News Articles

Bruker (BRKR) PT Raised to $60 at Citi

Wed, 08 Jul 2026 05:47:26 -0400

Citi analyst Patrick Donnelly raised the price target on Bruker (NASDAQ: BRKR) to $60.00 (from $44.00) while maintaining a Neutral rating.

Bruker (BRKR) PT Raised to $70 at Leerink

Tue, 07 Jul 2026 06:19:50 -0400

Leerink analyst Puneet Souda raised the price target on Bruker (NASDAQ: BRKR) to $70.00 (from $60.00) while maintaining a Outperform rating.

The analyst comments "In this report we investigate BRKR's recent AI trade (BRKR shares up ~66% over the last 3 months vs. S&P 500 +14%, LST peer group up ~20%) driven by their semi-exposed businesses (~$350M sales, ~9-10% of BRKR); semi metro has seen orders up 20%+ in 4Q25 and 1Q26. While one can argue that AI upside has mostly been captured within BRKR multiple at this point (~15x 2027E EV/ EBITDA vs. peer group ~17-18x), we still see room

Bruker (BRKR) PT Raised to $70 at Leerink

Tue, 07 Jul 2026 06:19:50 -0400

Leerink analyst Puneet Souda raised the price target on Bruker (NASDAQ: BRKR) to $70.00 (from $60.00) while maintaining a Outperform rating.

Bruker (BRKR) PT Raised to $70 at Guggenheim

Mon, 29 Jun 2026 06:55:01 -0400

Guggenheim analyst Subbu Nambi raised the price target on Bruker (NASDAQ: BRKR) to $70.00 (from $50.00) while maintaining a Buy rating.

Bruker (BRKR) PT Raised to $60 at Barclays

Wed, 24 Jun 2026 02:59:10 -0400

Barclays analyst Luke Sergott raised the price target on Bruker (NASDAQ: BRKR) to $60.00 (from $53.00) while maintaining a Overweight rating.

Form 4 BRUKER CORP For: Jun 15 Filed by: Munch Mark

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654279.html

Form 4 BRUKER CORP For: Jun 15 Filed by: Munch Mark

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654279.html

Form 144 BRUKER CORP Filed by: Munch Mark

Mon, 15 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260615/26648007.html

Form 144 BRUKER CORP Filed by: Munch Mark

Mon, 15 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260615/26648007.html

Bruker (BRKR) files mixed shelf

Fri, 12 Jun 2026 16:22:22 -0400

Bruker (NASDAQ: BRKR) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Depositary Shares

Subscription Rights

Purchase Contracts

Bruker (BRKR) files mixed shelf

Fri, 12 Jun 2026 16:22:22 -0400

Bruker (NASDAQ: BRKR) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Depositary Shares

Subscription Rights

Purchase Contracts

Form S-3ASR BRUKER CORP

Fri, 12 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260612/26641007.html

Form S-3ASR BRUKER CORP

Fri, 12 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260612/26641007.html

Bruker demonstrates expanded microbiology diagnostics portfolio at ASM

Thu, 04 Jun 2026 07:03:02 -0400

Bruker Corporation (NASDAQ: BRKR) presented its expanded microbiology and infection diagnostics portfolio at ASM Microbe 2026, showcasing developments in microbial identification, sepsis diagnostics, molecular testing, and next-generation sequencing workflows.

The company highlighted enhanced clinical capabilities of its MALDI Biotyper CA System through FDA Claims 7 and 8, which support broader microbial identification in clinical laboratories. The system now includes MBT Compass HT CA software, MBT FAST Shuttle US IVD, and an expanded FDA-cleared reference library covering 549 clinically validated microbial species across bacteria, anaerobes, and yeasts.

Bruker introduced several new solutions for MALDI Biotyper RUO/GP systems to the U.S. market, including the

Bruker demonstrates expanded microbiology diagnostics portfolio at ASM

Thu, 04 Jun 2026 07:03:02 -0400

Bruker introduced several new solutions for MALDI Biotyper RUO/GP systems to the U.S. market, including the

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

WASHINGTON--(BUSINESS WIRE)-- At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker launches timsMRMS mass spectrometry platform for energy research

Tue, 02 Jun 2026 11:29:43 -0400

Bruker Corporation (NASDAQ: BRKR) announced the launch of its timsMRMS mass spectrometry system at the ASMS conference. The platform combines Trapped Ion Mobility Spectrometry with Magnetic Resonance Mass Spectrometry for analyzing complex molecular structures in energy applications.

The system provides mass resolution exceeding 10 million and sub-parts-per-million mass accuracy, according to the company's press release. The technology targets researchers working in petroleomics, sustainable fuels, and energy storage materials.

The timsMRMS platform addresses two primary applications in energy research. For lithium battery development, the system analyzes electrolyte formulations and molecular changes during charge-discharge cycles. For biofuels research, it examines the molecular composition of

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

SAN DIEGO--(BUSINESS WIRE)-- At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced energy storage. The timsMRMS is an innovative platform that combines Trapped Ion Mobility Spectrometry (TIMS) with extreme-resolution Magnetic Resonance Mass Spectrometry (MRMS), to unravel the complex molecular makeup of challenging fossil fuels and green energy materials. It accomplishes this with unparalleled mass resolution (>10M) and sub-parts-per-million mass accuracy, plus isotope fine structure identification-confirmation, which enables the most confident identification of molecular species in ultra-complex mixtures.

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker (BRKR) PT Raised to $64 at BofA Securities

Tue, 02 Jun 2026 05:12:14 -0400

BofA Securities analyst Michael Ryskin raised the price target on Bruker (NASDAQ: BRKR) to $64.00 (from $49.00) while maintaining a Buy rating.